Skip to main content

Table 1 Antibody or serum neutralizing activities by cell type

From: Comparative neutralizing potencies of antibodies suggest conservation as well as mechanistic differences in human cytomegalovirus entry into epithelial and endothelial cells

SpeciesSerum or antibodytargetaneutralization IC50(ng/mL)IC50ratio
(endothelial/epithelial)
epithelialendothelial 
humanserum 1pan CMV682788.31.16
serum 2260926251.01
serum 3278745571.64
serum 479145575.75
serum 5176937422.12
serum6146710520.72
serum 7710552.20.78
serum 8725924.81.28
HIGd10570.00.67
TRL345gB91.095.41.05
TRL310PC0.2860.3181.11
2–250.5250.3740.71
rabbit57.422.919.70.86
276.134.824.70.71
α-UL130bPC (UL130)1429c685c0.48
α-UL131bPC (UL131A)62.6c87.9c1.40
15.1gH1211160.96
58.52092201.05
223.41562401.54
347.33912920.75
70.736.529.50.81
124.4gH/gL67.549.10.73
270.736.719.20.52
316.249.834.20.69
324.479.450.80.64
  1. asee Main Text for references
  2. bpolyclonal rabbit anti-peptide sera
  3. cserum values are based on an assumed serum IgG concentration of 10 mg/mL
  4. dCytoGam® (purified pooled polyclonal human IgG)